{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-009196","form_type":"8-K","ticker":"LRMR","cik":"0001374690","company_name":"Larimar Therapeutics, Inc.","filed_at":"2025-01-27T23:59:59+00:00","discovered_at":"2026-05-14T18:03:03.463750+00:00","generated_at":"2026-05-27T09:08:13.585465+00:00","sec_items":["5.02","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"Larimar grants performance-based PSUs to four top executives","bullets":["CEO Carole Ben-Maimon receives 100,000 PSUs tied to regulatory milestones.","CFO Michael Celano gets 50,000 PSUs; CDO Gopi Shankar and CMO Russell Clayton each get 25,000.","PSUs vest 50% upon milestone achievement determination and 50% one year later.","All grants made Jan 22, 2025 under the 2020 Equity Incentive Plan; forfeiture upon termination before vesting."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-009196","json":"https://secwatch.observer/filing/0000950170-25-009196.json","markdown":"https://secwatch.observer/filing/0000950170-25-009196.md","text":"https://secwatch.observer/filing/0000950170-25-009196.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1374690/000095017025009196/0000950170-25-009196-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1374690/000095017025009196/lrmr-20250122.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-27T09:08:13.585465+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}